EUVIMEDEUVIMED entdecken
Crossref

Is aberrant N-glucosylation relevant to recognise anti-MOG antibodies in Rett syndrome?

Feliciana Real-Fernández, Giulia Pacini, Francesca Nuti, Giulia Conciarelli, Claudio De Felice, Joussef Hayek, Paolo Rovero, Anna Maria Papini

Substantia · 2019

DOI: 10.13128/substantia-632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Substantia, 2019. Verfasst von Feliciana Real-Fernández und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibodies against myelin oligodendrocyte glycoprotein (MOG) are associated to several disorders, and their occurrence in patients presenting an acquired demyelinating disease affects a higher proportion of paediatric subjects, as compared to adults. Despite heterogeneity in clinical presentation, few connexions have been reported between the progressive neurodevelopmental disorder affecting child’s brain development and cognitive ability, i.e. Rett syndrome (RTT), and a demyelination process. In order to identify the possible target of humoral autoimmune response in RTT patients, we set-up a home-made solid-phase ELISA, using the recombinant extracellular portion of human MOG(1-117) as an antigen. The screening to evaluate anti-MOG antibodies in RTT patient sera, compared to other relative non-RTT pervasive developmental disorders (non-RTT PDD), including mainly autism, and a healthy control group gave uncertain results. In fact, Student t-test and Mann-Whitney unpaired t test showed that differences in both IgG and IgM antibody titres between the different patient populations, were not statistically significant. We can conclude that the absence of anti-MOG antibody recognition in RTT has possibly to be ascribed to a different relevant protein folding and/or to the lack of a relevant aberrant post-translational modification, such as N-glucosylation, that we previously demonstrated, for the first time, fundamental to recognize antibodies in RTT.

Zitieren

APA

Real-Fernández, F., Pacini, G., Nuti, F., Conciarelli, G., Felice, C. D., Hayek, J., Rovero, P., & Papini, A. M. (2019). Is aberrant N-glucosylation relevant to recognise anti-MOG antibodies in Rett syndrome?. Substantia. https://doi.org/10.13128/substantia-632

Vancouver

Real-Fernández F, Pacini G, Nuti F, Conciarelli G, Felice CD, Hayek J, et al. Is aberrant N-glucosylation relevant to recognise anti-MOG antibodies in Rett syndrome?. Substantia. 2019. doi:10.13128/substantia-632

BibTeX
@article{RealFernndez2019,
  author = {Real-Fernández, Feliciana and Pacini, Giulia and Nuti, Francesca and Conciarelli, Giulia and Felice, Claudio De and Hayek, Joussef and Rovero, Paolo and Papini, Anna Maria},
  title = {Is aberrant N-glucosylation relevant to recognise anti-MOG antibodies in Rett syndrome?},
  journal = {Substantia},
  year = {2019},
  doi = {10.13128/substantia-632}
}
Kostenlos starten →